#
# List of treatments for testing.  Each line is the following format:
#
# Gene\tVariant\tTumorType\tTreatments\tLevel
#

# Test KIT
KIT	N505I	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib; 2B: Sorafenib;
KIT	N505I	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib; 2B: Sorafenib;
KIT	N505I	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	N505I	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	N505I	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	N505L	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib; 2B: Sorafenib;
KIT	N505L	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	N505L	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	N505L	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	M541L	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib; 2B: Sorafenib;
KIT	M541L	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	M541L	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	M541L	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	M541C	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib; 2B: Sorafenib;
KIT	M541C	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	M541C	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	M541C	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	Y553N	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib; 2B: Sorafenib;
KIT	Y553N	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	Y553N	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	Y553N	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	Y553C	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib; 2B: Sorafenib;
KIT	Y553C	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	Y553C	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	Y553C	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	R643W	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib; 2B: Sorafenib;
KIT	R643W	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	R643W	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	R643W	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	D737N	Gastrointestinal Stromal Tumor
KIT	D737N	Melanoma
KIT	D737N	Colorectal Cancer
KIT	D737N	Thymic Tumor
KIT	C809G	Gastrointestinal Stromal Tumor	1: Regorafenib; 2A: Sorafenib; 2B: Imatinib; 2B: Sunitinib;
KIT	C809G	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	C809G	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	C809G	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	K642E	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib; 2B: Sorafenib;
KIT	K642E	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	K642E	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	K642E	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	K642G	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib; 2B: Sorafenib;
KIT	K642G	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	K642G	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	K642G	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	V654A	Gastrointestinal Stromal Tumor	1: Sunitinib; 1: Regorafenib; 2B: Imatinib; 2B: Sorafenib;
KIT	V654A	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	V654A	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	V654A	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	V654G	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib; 2B: Sorafenib;
KIT	V654G	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	V654G	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	V654G	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	T670I	Gastrointestinal Stromal Tumor	1: Sunitinib; 1: Regorafenib; 2B: Imatinib; 2B: Sorafenib;
KIT	T670I	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	T670I	Colorectal Cancer A	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	T670I	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	T670C	Gastrointestinal Stromal Tumor	1: Imatinib; 1: Sunitinib; 1: Regorafenib; 2B: Sorafenib;
KIT	T670C	Melanoma	2A: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	T670C	Colorectal Cancer	2B: Imatinib; 2B: Sunitinib; 2B: Regorafenib; 2B: Sorafenib;
KIT	T670C	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 2B: Imatinib; 2B: Regorafenib;
KIT	D816A	Gastrointestinal Stromal Tumor	3B: Avapritinib;
KIT	D816A	Melanoma	2A: Imatinib; 3B: Avapritinib;
KIT	D816A	Colorectal Cancer	3B: Avapritinib;
KIT	D816A	Mastocytosis	3A: Avapritinib;
KIT	D816A	Thymic Tumor	2A: Sunitinib; 2A: Sorafenib; 3B: Avapritinib;
MTOR	L2427Q	Renal Clear Cell Carcinoma	3A: Temsirolimus;
